# US 4,391,817 A · Pyrrolo-diazepine derivatives and their pharmaceutical compositions

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 4,391,817 A
- Document ID: US4391817A
- Status: Granted
- Kind: A
- Application number: 06/381,271
- Filed: 1982-05-24
- Granted: 1983-07-05
- Earliest claimed: 1981-06-08
- Assignees: Gruppo Lepetit S.p.A.
- Inventors: Luigi Mariani; Giorgio Tarzia
- Web page: https://patentgrep.com/patent/US4391817A

## CPC

- C07D 487/04: Ortho-condensed systems
- A61P 25/08: Antiepileptics; Anticonvulsants
- A61P 25/20: Hypnotics; Sedatives
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

A new class of pyrrolo-diazepines with anticonvulsant and anti-anxiety activity of the general formula ##STR1## wherein R is (C.sub.1 -C.sub.4)alkyl, R.sub.1 is chloro, bromo or nitro, R.sub.2 is hydrogen or (C.sub.1 -C.sub.4)alkyl and R.sub.3 is hydrogen, chloro, bromo, fluoro, trifluoromethyl or methoxy. The new compounds are prepared starting from the corresponding compounds wherein R.sub.1 is hydrogen through halogenation or nitration. Pharmaceutical preparations containing the new compounds of formula I are also described.

## Claims

### Claim 1

A pyrrolo[ 3,4-e][1,4]diazepin-2(1H)-one of the formula ##STR4## wherein R represents methyl, ethyl, propyl, 1-methylethyl, butyl, 1-methylpropyl, 2-methylpropyl, or 1,1-dimethylethyl, R.sub.1 designates a chlorine or bromine atom or a nitro group, R.sub.2 represents hydrogen, methyl, ethyl, propyl, 1-methylethyl, butyl, 1-methylpropyl, 2-methylpropyl, or 1,1-dimethylethyl, and R.sub.3 is hydrogen, chloro, bromo, fluoro, trifluoromethyl or methoxy.

### Claim 2 (depends on 1)

A compound according to claim 1 wherein R is methyl, R.sub.1 is chloro, bromo or nitro, R.sub.2 is hydrogen or methyl and R.sub.3 is hydrogen, chloro or fluoro.

### Claim 3 (depends on 1)

A compound according to claim 1 wherein R is methyl, R.sub.1 is chloro, bromo or nitro, R.sub.2 is hydrogen and R.sub.3 is hydrogen or chloro.

### Claim 4

A process for preparing a compound of formula ##STR5## wherein R represents methyl, ethyl, propyl, 1-methylethyl, butyl, 1-methylpropyl, 2-methylpropyl, or 1,1-dimethylethyl, R.sub.1 designates a chlorine or bromine atom or a nitro group, R.sub.2 represents hydrogen, methyl, ethyl, propyl, 1-methylethyl, butyl, 1-methylpropyl, 2-methylpropyl, or 1,1-dimethylethyl, and R.sub.3 is hydrogen, chloro, bromo, fluoro, trifluoromethyl or methoxy, which comprises nitrating or halogenating a compound of formula II ##STR6## wherein R, R.sub.2 and R.sub.3 are as defined above.

### Claim 5 (depends on 1)

An anticonvulsant and antianxiety pharmaceutical preparation containing an effective amount of a compound of claim 1 as the active ingredient, along with a suitable pharmaceutical carrier.

### Claim 6 (depends on 5)

A pharmaceutical preparation according to claim 5 which contains from 2.5 to about 150 mg of active ingredient per unit dosage form.